AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)
On Monday, AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)’s shares declined -11.93% to $0.0406.
AEZS has beta value of 1.76. The company has the market capitalization of $30.95 billion. Return on assets ratio of the company was -65.60% while its return on equity ratio was -251.50%. ATR value of company was 0.01 while stock volatility for week was 15.76% while for month was 17.25%.
The mean estimate for the short term price target for AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) stands at $0.97 according to 3 Analysts. The higher price target estimate for the stock has been calculated at $1.75 while the lower price target estimate is at $0.15.
Analysts mean recommendation for the stock is 1.70 . This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company engaged in developing treatments in oncology, endocrinology and women’s health. The Company has three wholly owned direct and indirect subsidiaries: AEZS GmbH.
Amazon.com, Inc. (NASDAQ:AMZN)
Amazon.com, Inc. (NASDAQ:AMZN)’s shares gained 0.85% to $647.81.
AMZN is currently valued at $301.11 billion. The company has 468.76 million shares outstanding and 67.70% shares of the company were owned by institutional investors. The company has 3.02 value in price to sale ratio while price to book ratio was recorded as -24.39. The company exchanged hands with 7.44 million shares as compared to its average daily volume of 4.40 million shares. It beta stands at 0.89.
The mean estimate for the short term price target for Amazon.com, Inc. (NASDAQ:AMZN) stands at $721.42 according to 38 Analysts. The higher price target estimate for the stock has been calculated at $800.00 while the lower price target estimate is at $490.00.
Analysts mean recommendation for the stock is 1.80. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Amazon.com, Inc. (Amazon.com) is an e-commerce company. The Company sells a range of products and services through its Websites. The Company’s products are offered through consumer-facing Websites, which include merchandise and content that it purchases for resale from vendors and those offered by third-party sellers.
National-Oilwell Varco, Inc. (NYSE:NOV)
At the end of Monday’s trade, National-Oilwell Varco, Inc. (NYSE:NOV)‘s shares surged 1.18% to $37.77.
NOV offered 10.10% EPS for prior five years. The company has 7.00% return on equity value while its ROI ratio was 10.80%. The company has $14.03 billion market capitalizations and the institutional ownership was 97.90%. Its price to book ratio was 0.79. Volatility of the stock was 3.28% for the week while for the month booked as 3.53%.
The mean estimate for the short term price target for National-Oilwell Varco, Inc. (NYSE:NOV) stands at $38.86 according to 28 Analysts. The higher price target estimate for the stock has been calculated at $55.00 while the lower price target estimate is at $29.00.
Analysts mean recommendation for the stock is 3.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
National Oilwell Varco, Inc. (NOV) is engaged in providing design, manufacture and sale of equipment and components used in oil and gas drilling, completion and production operations.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.